TUCSON, Ariz.--Sinfonía Family Services, the behavioral health subsidiary of national company Sinfonía HealthCare Corporation, founded by Fletcher J. McCusker, former CEO and founder of Providence Service Corporation (Nasdaq:PRSC), has announced expansion plans in Louisiana and Maine.
LEESBURG, Va.--K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced plans to release third quarter of fiscal 2014 financial results after market close on October 29th.
NEW YORK, N.Y.--Water.org has announced a $2.9 million three-year grant from The Leona M. and Harry B. Helmsley Charitable Trust to provide access to safe water and sanitation to 42,000 people in Ghana and Kenya.
WARSAW, Ind.--Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced today that it will release third quarter 2014 financial results for the period ending September 27, 2014 before the market opens on Thursday, October 30, 2014. Symmetry Medical will host an accompanying conference call at 8:00 a.m. ET on Thursday, October 30, 2014.
OKLAHOMA CITY--Foundation Healthcare Inc. (OTCQB:FDNH), an owner and operator of surgery focused hospitals that facilitate and enhance the surgical experience for surgeons and their patients, announced today it will host an earnings call to discuss the Company's third quarter 2014 financial results at 4:30 p.m. EDT (3:30 p.m. CDT) on Wednesday, October 29, 2014.
BAGNEUX, France--DBV Technologies (Euronext: DBV - ISIN: FR0010417345), a clinical-stage specialty biopharmaceutical company announced today that it intends to offer and sell, subject to market and other conditions, up to 2,673,641 of its ordinary shares in a global offering, which is comprised of an offer of ordinary shares in the form of American Depositary Shares, or ADSs, in the United States, Canada and countries outside of France in an underwritten public offering through U.S. underwriters and an offer of ordinary shares in France and countries outside of the United States and Canada in a concurrent registered private placement through international underwriters.
PHILADELPHIA--Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has retained Squire Patton Boggs (SPB) to serve as its global government relations team in an effort to help find additional pathways for testing Hemispherx's flagship experimental anti-viral Ampligen® and approved anti-viral (HPV) Alferon® N against the devastating Ebola virus.